Publication | Open Access
Preventative Effects of Rosiglitazone on Restenosis After Coronary Stent Implantation in Patients With Type 2 Diabetes
244
Citations
35
References
2004
Year
We demonstrated that treatment with rosiglitazone significantly reduces in-stent restenosis in diabetic patients with CAD who underwent coronary stent implantation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1